Ursodeoxycholic acid attenuates the expression of proinflammatory cytokines in periodontal cells

BACKGROUND: Ursodeoxycholic acid (UDCA) is one of the first‐line therapeutic medications used in treatment of cholestatic liver disease. Considering that periodontitis is epidemiologically linked to liver diseases, the question arises weather UDCA holds anti‐inflammatory properties on periodontal he...

Descripción completa

Detalles Bibliográficos
Autores principales: Talebian, Reza, Panahipour, Layla, Gruber, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Translational Periodontology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496100/
https://www.ncbi.nlm.nih.gov/pubmed/31960968
http://dx.doi.org/10.1002/JPER.19-0013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496100/
https://www.ncbi.nlm.nih.gov/pubmed/31960968
http://dx.doi.org/10.1002/JPER.19-0013

Ejemplares similares